Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
19:10
Christa Pike, a death-row inmate in Tennessee, reports constant physical pain and psychological trauma one month after the failure of her execution on September 30
19:08
Petrișor Peiu accuses the Nicușor Dan regime over rising energy prices
19:00
Sorin Grindeanu says the budget revision ensures payment of pensions, medicines and debts owed to companies
18:51
The government approves a 6.5% pay increase at Oil Terminal to retain staff and ensure operational continuity
18:42
Alexandru Stoica announces the payment of 1.1 billion lei in arrears for works funded through the Anghel Saligny program
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
